GERD (Gastroesophageal Reflux Disease)RGO à travNCT00833573

National Survey on GERD Patients (Adults and Children)

An observational study of GERD (Gastroesophageal Reflux Disease), run by AstraZeneca at 1,053 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Trial summary

To describe GERD digestive expression according to ages: - children (from 0 to 23 months) and (24 months and more)- adults (from 18 to 29 years old), (from 30 to 39 years old), (from 40 to 49 years old), (from 50 to 59 years old), (more than 60 years old) Read more about this study

Who is it for?: Any age
Conditions the study is for: GERD (Gastroesophageal Reflux Disease)
How many people: 4,400 participants
Where: 1,053 sitesFrance
Study dates: Jan 2009to Oct 2009
Phase: Observational
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages Any age
All sexes
No healthy volunteers
Child, Adult, Older adult

Study population: For GP : the first 3 consecutive adult patients and the first children seen during the GP's visit with a diagnosis of GERD.For Paediatrics : the first 2 consecutive children seen during the Paediatric's visit with a diagnosis of GERD.

Who may be able to join

Adults : - Male or female > or = 18 years old - With at least one GERD typical clinical sign (pyrosis and / or acid regurgitations).- Not receiving any GERD treatment within the 3 previous months.
Children :- Male or female < 18 years old - With GERD digestive clinical signs during the consultation (receiving treatment or not)- Whose parents or legal guardian gave oral approval to the child participation in the survey.

Who cannot join

Trial locations and contacts

1,053 sites in 1 country.

City, postcode or hospital

300 sites in 1 country

France300 sites

Research Site
Abbaretz
Research Site
Abbeville
Research Site
Acheux-en-Amiénois
Research Site
Achicourt
Research Site
Adriers
Research Site
Agen
Research Site
Aigrefeuille-sur-Maine
Research Site
Aire-sur-l'Adour
Research Site
Aire-sur-la-Lys
Research Site
Airvault
Research Site
Aix-en-Othe
Research Site
Aix-en-Provence
Research Site
Aix-les-Bains
Research Site
Aizenay
Research Site
Ajaccio
Research Site
Albi
Research Site
Alençon
Research Site
Alès
Research Site
Alfortville
Research Site
Allonnes
Research Site
Althen-des-Paluds
Research Site
Ambès
Research Site
Ambillou-Château
Research Site
Amboise
Research Site
Amiens
Research Site
Andernos-les-Bains
Research Site
Angers
Research Site
Anglet
Research Site
Angoulême
Research Site
Annecy
Research Site
Annecy-le-Vieux
Research Site
Annezin
Research Site
Annonay
Research Site
Antibes
Research Site
Apremont
Research Site
Arc-et-Senans
Research Site
Arcachon
Research Site
Ardentes
Research Site
Argences
Research Site
Argentat
Research Site
Argenteuil
Research Site
Argenton-sur-Creuse
Research Site
Arnèke
Research Site
Arpajon
Research Site
Arques-la-Bataille
Research Site
Arras
Research Site
Ars
Research Site
Ars-sur-Moselle
Research Site
Art-sur-Meurthe
Research Site
Artenay
Research Site
Arudy
Research Site
Arzon
Research Site
Asnières-sur-Seine
Research Site
Aubenas
Research Site
Aubervilliers
Research Site
Auby
Research Site
Aucamville
Research Site
Auch
Research Site
Aulnay-sous-Bois
Research Site
Auray
Research Site
Aurec-sur-Loire
Research Site
Aussonne
Research Site
Auxerre
Research Site
Auxi-le-Château
Research Site
Auxon
Research Site
Auxonne
Research Site
Avelin
Research Site
Avesnelles
Research Site
Avignon
Research Site
Avord
Research Site
Avricourt
Research Site
Bâgé-le-Châtel
Research Site
Bagnères-de-Luchon
Research Site
Bagneux
Research Site
Bagnolet
Research Site
Bagnols-sur-Cèze
Research Site
Baignes Ste Radegonde
Research Site
Baillargues
Research Site
Bailleul
Research Site
Bais
Research Site
Balbigny
Research Site
Bandol
Research Site
Banyuls de la Marenda
Research Site
Barbentane
Research Site
Barbezieux-Saint-Hilaire
Research Site
Bardos
Research Site
Bassens
Research Site
Bastia
Research Site
Baugé
Research Site
Baulon
Research Site
Bayeux
Research Site
Bayonne
Research Site
Beaucouzé
Research Site
Beaumesnil
Research Site
Beaumont
Research Site
Beaumont-de-Pertuis
Research Site
Beaumont-Hague
Research Site
Beautor
Research Site
Beauvais
Research Site
Beauvoir-sur-Niort
Research Site
Bécon-les-Granits
Research Site
Bégard
Research Site
Belleville-sur-Meuse
Research Site
Bérat
Research Site
Bergerac
Research Site
Bernay
Research Site
Bersée
Research Site
Béruges
Research Site
Besançon
Research Site
Béthisy-Saint-Pierre
Research Site
Béthune
Research Site
Béville-le-Comte
Research Site
Béziers
Research Site
Biarritz
Research Site
Bignan
Research Site
Biscarrosse
Research Site
Bischheim
Research Site
Biver
Research Site
Bize-Minervois
Research Site
Blagnac
Research Site
Blangy-sur-Bresle
Research Site
Blanquefort
Research Site
Blaye
Research Site
Blénod-lès-Pont-à-Mousson
Research Site
Bobigny
Research Site
Bohain-en-Vermandois
Research Site
Boiscommun
Research Site
Bondues
Research Site
Bordeaux
Research Site
Bords
Research Site
Bormes-les-Mimosas
Research Site
Bosmie-l'Aiguille
Research Site
Bouc-Bel-Air
Research Site
Boucau
Research Site
Bouliac
Research Site
Boulogne-Billancourt
Research Site
Boulogne-sur-Gesse
Research Site
Boulogne-sur-Mer
Research Site
Bourbriac
Research Site
Bourg-en-Bresse
Research Site
Bourg-la-Reine
Research Site
Bourgoin
Research Site
Bourron-Marlotte
Research Site
Bracieux
Research Site
Braine
Research Site
Bram
Research Site
Brantôme
Research Site
Brax
Research Site
Bresles
Research Site
Brest
Research Site
Bretignolles-sur-Mer
Research Site
Briançon
Research Site
Brienne-le-Château
Research Site
Brienon-sur-Armançon
Research Site
Brignais
Research Site
Brioude
Research Site
Bruay-la-Buissière
Research Site
Brunstatt
Research Site
Bruyères
Research Site
Bruz
Research Site
Bry-sur-Marne
Research Site
Bubry
Research Site
Bures-sur-Yvette
Research Site
Burie
Research Site
Cachan
Research Site
Caen
Research Site
Cagnes-sur-Mer
Research Site
Cahuzac-sur-Vère
Research Site
Caluire-et-Cuire
Research Site
Cambrai
Research Site
Campagne-lès-Hesdin
Research Site
Candé
Research Site
Canet-en-Roussillon
Research Site
Cannes
Research Site
Cannes La Bocca
Research Site
Cany-Barville
Research Site
Capbreton
Research Site
Capdenac-Gare
Research Site
Carbon-Blanc
Research Site
Carcassonne
Research Site
Carentan
Research Site
Carhaix-Plouguer
Research Site
Carrières-sur-Seine
Research Site
Carros
Research Site
Carrouges
Research Site
Carry-le-Rouet
Research Site
Carvin
Research Site
Cassis
Research Site
Casteljaloux
Research Site
Castelnau-de-Guers
Research Site
Castelnaudary
Research Site
Castets-en-Dorthe
Research Site
Castres
Research Site
Catillon-sur-Sambre
Research Site
Catus
Research Site
Caulnes
Research Site
Cavaillon
Research Site
Cavignac
Research Site
Celles-sur-Plaine
Research Site
Cénac
Research Site
Cesson
Research Site
Cesson-Sévigné
Research Site
Cestas
Research Site
Chabris
Research Site
Chalais
Research Site
Châlette-sur-Loing
Research Site
Chalonnes-sur-Loire
Research Site
Châlons-en-Champagne
Research Site
Chamalières
Research Site
Chambéry
Research Site
Chambon-sur-Voueize
Research Site
Chamonix
Research Site
Champagne-sur-Seine
Research Site
Champagnole
Research Site
Champcueil
Research Site
Champeaux
Research Site
Champenoux
Research Site
Champigny-sur-Marne
Research Site
Champniers
Research Site
Champs-sur-Marne
Research Site
Chantepie
Research Site
Chantilly
Research Site
Chaource
Research Site
Charleville-Mézières
Research Site
Charmont-sous-Barbuise
Research Site
Chartres
Research Site
Chasseneuil-sur-Bonnieure
Research Site
Château-Arnoux-Saint-Auban
Research Site
Château-sur-Epte
Research Site
Châteaubriant
Research Site
Châteaugay
Research Site
Châteaumeillant
Research Site
Châteauneuf-en-Thymerais
Research Site
Châteauneuf-sur-Cher
Research Site
Châteauroux
Research Site
Châtel-Censoir
Research Site
Châtenay-Malabry
Research Site
Châtillon-sur-Marne
Research Site
Chauché
Research Site
Cherbourg Octeville Cedex
Research Site
Chinon
Research Site
Ciboure
Research Site
Cinq-Mars-la-Pile
Research Site
Claix
Research Site
Clamart
Research Site
Clermont-Ferrand
Research Site
Clichy
Research Site
Clichy-sous-Bois
Research Site
Clouange
Research Site
Cluny
Research Site
Coincy
Research Site
Colmar
Research Site
Colomars
Research Site
Colombes
Research Site
Combloux
Research Site
Combs-la-Ville
Research Site
Commentry
Research Site
Compiègne
Research Site
Concarneau
Research Site
Conty
Research Site
Coquelles
Research Site
Cornebarrieu
Research Site
Corseul
Research Site
Coudekerque-Branche
Research Site
Couffé
Research Site
Coulanges-lès-Nevers
Research Site
Coulommiers
Research Site
Courbevoie
Research Site
Cournon-d'Auvergne
Research Site
Courrières
Research Site
Courseulles-sur-Mer
Research Site
Coutouvre
Research Site
Couze-et-Saint-Front
Research Site
Coye-la-Forêt
Research Site
Crécy-sur-Serre
Research Site
Créteil
Research Site
Creutzwald
Research Site
Crèvecœur-le-Grand
Research Site
Creysse
Research Site
Criel-sur-Mer
Research Site
Criquetot-l'Esneval
Research Site
Croix
Research Site
Cros-de-Cagnes
Research Site
Crosne
Research Site
Cuers
Research Site
Cugnaux
Research Site
Cusset
Research Site
Dambach-la-Ville
Research Site
Daoulas
Research Site
Daux
Research Site
Décines-Charpieu
Research Site
Decize
Research Site
Derval
Research Site
Dieppe
Research Site
Dijon
Research Site
Dinard
Research Site
Divion
Research Site
Dole
Research Site
Domfront
Research Site
Domont

Other trials in France

About this study

Conditions: GERD (Gastroesophageal Reflux Disease)
Keywords: GERD digestive expression, ages
Medical subject headings: Gastroesophageal Reflux

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT00833573
Study group	Role	What they receive
1		For GP : the first 3 consecutive adult patients and the first children seen during the GP's visit with a diagnosis of GERD.
2		For Paediatrics : the first 2 consecutive children seen during the Paediatric's visit with a diagnosis of GERD.

What is being measured

The primary outcome is the main question the study is designed to answer.

To describe GERD digestive expression according to ages: - children (from 0-23 months) and (24 months and more)- adults (from 18-29 years old), (from 30-39 years old), (from 40-49 years old), (from 50-59 years old), (more than 60 years old)
Measured: once

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

Jan 2009Oct 2009

First posted2 Feb 2009 (estimated)
Study startJan 2009
Study completionOct 2009

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Other trials for GERD (Gastroesophageal Reflux Disease)Studies of the same condition, open and under way.
More trials run by AstraZenecaThe sponsor's other registered studies.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Observational
Observational model: Cohort
Time perspective: Cross-sectional
Enrolment: 4,400 participants (estimated)

IDs, dates and publications

ClinicalTrials.gov ID: NCT00833573
Sponsor's protocol ID: NIS-GFR-DUM-2008/2
Acronym: RGO à trav
Status last verified: Nov 2009
First submitted: 30 Jan 2009
Last updated: 17 Nov 2009
Results posted: No
Data monitoring committee: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

RecruitingObservational study
A Study to Evaluate the Efficacy and Safety of Long-term Administration of K-CAB Tab./K-CAB ODT(Tegoprazan) 25 mg as Maintenance Therapy Following the Treatment of GERD
Maintenance Therapy Following Treatment for Gastroesophageal Reflux Disease(GERD)
Active, not recruitingObservational study
RETHINK REFLUX Registry
Gastroesophageal Reflux
Recruiting
Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial
Mitral Regurgitation
Not yet recruitingPhase 4
Effects of Tirzepatide on Esophagogastric Junction Mechanics, Reflux Burden, and Gastric Physiology in Adults With Obesity
Obese Adults
Recruiting
Mesh Vs Pledgets for Repair of Paraesophageal Hernia
Paraesophageal Hernia, GERD

All GERD (Gastroesophageal Reflux Disease) trials

Study at a glance

From the registry record, last updated by the sponsor on 17 Nov 2009. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: National Survey on GERD Patients (Adults and Children)
ClinicalTrials.gov ID: NCT00833573
Acronym / sponsor ID: RGO à trav / NIS-GFR-DUM-2008/2
Conditions: GERD (Gastroesophageal Reflux Disease)
Keywords: GERD digestive expression, ages
Study type: Observational
Recruitment status: Completed
Enrolment: 4,400 participants (estimated)
Lead sponsor: AstraZenecaIndustry (pharma, biotech, devices)
Study start: Jan 2009
Study completion: Oct 2009 (actual)
First posted: 2 Feb 2009 (estimated)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Study design

Observational model: Cohort
Time perspective: Cross-sectional
Number of arms: 2

Arm	Type	Receives
1	–	–For GP : the first 3 consecutive adult patients and the first children seen during the GP's visit with a diagnosis of GERD.
2	–	–For Paediatrics : the first 2 consecutive children seen during the Paediatric's visit with a diagnosis of GERD.

Who may qualify

Sex: All
Healthy volunteers: Not accepted
Age groups: Child, Adult, Older adult
Study population: For GP : the first 3 consecutive adult patients and the first children seen during the GP's visit with a diagnosis of GERD.For Paediatrics : the first 2 consecutive children seen during the Paediatric's visit with a diagnosis of GERD.

Key inclusion criteria (2 listed)

Adults : - Male or female > or = 18 years old - With at least one GERD typical clinical sign (pyrosis and / or acid regurgitations).- Not receiving any GERD treatment within the 3 previous months.
Children :- Male or female < 18 years old - With GERD digestive clinical signs during the consultation (receiving treatment or not)- Whose parents or legal guardian gave oral approval to the child participation in the survey.

Key exclusion criteria (1 listed)

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Primary outcome

To describe GERD digestive expression according to ages: - children (from 0-23 months) and (24 months and more)- adults (from 18-29 years old), (from 30-39 years old), (from 40-49 years old), (from 50-59 years old), (more than 60 years old)
Time frame: once

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 17 Nov 2009.

Related trials for GERD (Gastroesophageal Reflux Disease)

RecruitingObservational study
A Study to Evaluate the Efficacy and Safety of Long-term Administration of K-CAB Tab./K-CAB ODT(Tegoprazan) 25 mg as Maintenance Therapy Following the Treatment of GERD
Maintenance Therapy Following Treatment for Gastroesophageal Reflux Disease(GERD)
Active, not recruitingObservational study
RETHINK REFLUX Registry
Gastroesophageal Reflux
Recruiting
Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial
Mitral Regurgitation
Not yet recruitingPhase 4
Effects of Tirzepatide on Esophagogastric Junction Mechanics, Reflux Burden, and Gastric Physiology in Adults With Obesity
Obese Adults
Recruiting
Mesh Vs Pledgets for Repair of Paraesophageal Hernia
Paraesophageal Hernia, GERD

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Alain Castaigne study director

AstraZeneca

1,053 sites in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

An observational study of GERD (Gastroesophageal Reflux Disease), run by AstraZeneca at 1,053 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Nov 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1,053 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To describe GERD digestive expression according to ages: - children (from 0-23 months) and (24 months and more)- adults (from 18-29 years old), (from 30-39 years old), (from 40-49 years old), (from 50-59 years old), (more than 60 years old) (time frame: once). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00833573.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Nov 2009.